Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Spinal Mobilization With Arm Movement and Kaltenborn Mobilization in Adhesive Capsulitis (SMWAM)

23 juli 2026 bijgewerkt door: Riphah International University

Effects of Spinal Mobilization With Arm Movement and Kaltenborn Mobilization on Pain, Range of Motion, Functional Reaching, and Disability in Adhesive Capsulitis

To compare the effects of spinal mobilization with arm movement and Kaltenborn Mobilization on pain, range of motion, functional reaching, and disability in patients with Adhesive Capsulitis.

Studie Overzicht

Gedetailleerde beschrijving

A randomized clinical trial compared the effectiveness of Kaltenborn mobilization and muscle energy techniques in individuals with adhesive capsulitis. Seventy-six participants were randomly allocated into two treatment groups. Pain, shoulder range of motion, and disability were assessed using the Numeric Pain Rating Scale (NPRS), goniometry, and the Shoulder Pain and Disability Index (SPADI) at baseline and after four weeks of treatment. The findings demonstrated that Kaltenborn mobilization produced greater improvements in pain reduction, shoulder range of motion, and functional ability.

A quasi-experimental study evaluated the effects of Kaltenborn mobilization and muscle energy techniques in patients with chronic adhesive capsulitis. Participants received their respective manual therapy interventions in combination with conventional rehabilitation. Shoulder external rotation, shoulder abduction, pain intensity, and functional disability were assessed before and after treatment. The results indicated that Kaltenborn mobilization was more effective than muscle energy techniques in improving shoulder mobility, reducing pain, and enhancing functional outcomes.

A randomized controlled trial compared muscle energy techniques with Kaltenborn mobilization for improving shoulder range of motion in individuals with adhesive capsulitis. Outcomes were assessed at baseline and during follow-up using goniometric measurements. The findings showed that muscle energy techniques produced greater improvements in shoulder flexion and abduction, whereas rotational movements demonstrated no clear advantage over Kaltenborn mobilization.

A randomized clinical trial investigated the effects of Spinal Mobilization with Arm Movement (SMWAM) compared with the Maitland mobilization technique on shoulder function. Pain, shoulder range of motion, and muscle activity were evaluated before and after treatment. The results demonstrated that spinal mobilization with arm movement effectively reduced pain, normalized shoulder muscle activity, and increased shoulder range of motion.

A randomized controlled trial compared the effects of anterior and posterior Grade III Kaltenborn glides on shoulder function in patients with adhesive capsulitis. External rotation and functional ability were evaluated using goniometric measurements and the Shoulder Pain and Disability Index (SPADI). The findings indicated that posterior gliding mobilization resulted in greater improvements in external rotation and shoulder function than anterior gliding.

A randomized controlled trial examined the immediate effects of Spinal Mobilization with Arm Movement (SMWAM) on shoulder performance. The intervention involved cervical spinal mobilization combined with repeated active arm abduction. The study reported immediate improvements in shoulder movement and suggested that SMWAM enhances shoulder function by correcting cervical spinal alignment and stimulating joint mechanoreceptors.

Although both Spinal Mobilization with Arm Movement (SMWAM) and Kaltenborn Mobilization have demonstrated beneficial effects in reducing pain and improving shoulder mobility, existing evidence has primarily evaluated these techniques independently or compared them with other manual therapy approaches. Direct comparative evidence between SMWAM and Kaltenborn Mobilization in individuals with adhesive capsulitis remains limited, particularly regarding their effects on pain, range of motion, functional reaching, and disability. Therefore, further comparative research is warranted to determine the more effective intervention for optimizing functional recovery in patients with adhesive capsulitis.

Studietype

Ingrijpend

Inschrijving (Geschat)

50

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
      • Lahore, Punjab Province, Pakistan, 54000

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Age 35-50 years
  • Both male and female genders
  • Pain rating 3 to 7 on NPRS for at least 3 months
  • Idiopathic frozen shoulder
  • Stage II and III frozen shoulder
  • Positive Apley's Scratch test
  • Unilateral frozen shoulder
  • Frozen shoulder with at least 25% restricted ROM
  • Presence of global restriction in passive range of motion (PROM) in a capsular pattern (ER > ABD > IR)

Exclusion Criteria:

  • Arthritic shoulder
  • Rotator cuff disease
  • Post-traumatic stiff shoulder
  • Post-CABG shoulder-hand syndrome
  • Post-stroke frozen shoulder
  • Bilateral frozen shoulder
  • Complex Regional Pain Syndrome
  • Any fracture or other injury
  • Any systemic illness
  • Any inflammatory disease (Rheumatoid arthritis, gout)
  • Any neurological disease
  • Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty
  • Tendon calcification

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Spinal Mobilization with Arm Movement
Participants will be seated upright while the therapist applies a sustained transverse glide to the C4 spinous process toward the side opposite the affected shoulder. The glide will be maintained as the participant actively abducts the affected arm to the pain-free or maximum tolerated range and returns to the starting position. The technique will be performed for 10 repetitions per session, ensuring controlled movement, proper posture, and patient comfort throughout the intervention.
Intervention: Spinal Mobilization with Arm Movement (SMWAM) Position: Participant seated upright with neutral spine and head posture Technique: Sustained transverse glide applied to the C4 spinous process toward the side opposite the affected shoulder during active shoulder abduction Movement: Active shoulder abduction to the pain-free or maximum tolerated range, followed by return to the starting position while maintaining the glide Dosage: 10 repetitions per session Purpose: To reduce pain, improve shoulder mobility, and enhance functional movement.
Andere namen:
  • SMWAM
Experimenteel: Kaltenborn Mobilization
Following the application of a moist hot pack, participants will receive Kaltenborn Grade I glenohumeral traction followed by Grade III ventral glide and Grade III caudal glide in the same treatment session. Each mobilization will be performed for 15 repetitions, with a 30-second sustained hold and 10-second rest between repetitions, for a total treatment time of approximately 10 minutes. The techniques will be applied in standardized patient positions with appropriate scapular stabilization to improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Intervention: Kaltenborn Mobilization Technique (KMT) Pre-treatment: Moist hot pack application Techniques: Grade I glenohumeral traction, Grade III ventral glide, and Grade III caudal glide Dosage: 15 repetitions of each technique with a 30-second hold and 10-second rest between repetitions Duration: Approximately 10 minutes per session Purpose: To improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Andere namen:
  • KMT

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Pain by Numeric Pain Rating Scale (NPRS)
Tijdsspanne: 6 weeks
The Numeric Pain Rating Scale (NPRS) is an 11-point self-reported scale (0 = no pain, 10 = worst imaginable pain) used to assess pain intensity in clinical and research settings.
6 weeks
Range of Motion (External Rotation, Abduction, Internal Rotation)
Tijdsspanne: 6 weeks
A goniometer is a standard clinical instrument used to measure joint range of motion (ROM)
6 weeks
Functional Disability
Tijdsspanne: 6 weeks
The Shoulder Pain and Disability Index (SPADI) is a 13-item self-administered questionnaire used to assess shoulder pain and functional disability.
6 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Annum Manzoor, MS OMPT, Riphah International University

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 juli 2026

Primaire voltooiing (Geschat)

1 augustus 2026

Studie voltooiing (Geschat)

1 september 2026

Studieregistratiedata

Eerst ingediend

21 juli 2026

Eerst ingediend dat voldeed aan de QC-criteria

23 juli 2026

Eerst geplaatst (Werkelijk)

24 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

24 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

23 juli 2026

Laatst geverifieerd

1 juli 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren